175 related articles for article (PubMed ID: 15314520)
41. Papillomavirus-like particle vaccines for cervical cancer.
Schiller JT
Mol Med Today; 1999 May; 5(5):209-15. PubMed ID: 10322313
[TBL] [Abstract][Full Text] [Related]
42. Primary prevention of cervical cancer: prophylactic human papillomavirus vaccines.
Mandic A
J BUON; 2012; 17(3):422-7. PubMed ID: 23033276
[TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus immunogen that provides protective tumor immunity and induces tumor regression.
Marquez JP; Rivera R; Kang KH; Gardner MB; Torres JV
Viral Immunol; 2012 Apr; 25(2):141-52. PubMed ID: 22486305
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus: current status and issues of vaccination.
Malik H; Khan FH; Ahsan H
Arch Virol; 2014 Feb; 159(2):199-205. PubMed ID: 24022639
[TBL] [Abstract][Full Text] [Related]
45. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
46. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
Hantz S; Alain S; Denis F
Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
[TBL] [Abstract][Full Text] [Related]
47. Strategies for the prevention of cervical cancer by human papillomavirus vaccination.
Williamson AL; Passmore JA; Rybicki EP
Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392
[TBL] [Abstract][Full Text] [Related]
48. HPV-vaccination against cervical carcinoma: will it really work?
Gross G
Med Microbiol Immunol; 2007 Sep; 196(3):121-5. PubMed ID: 17318575
[TBL] [Abstract][Full Text] [Related]
49. HPV vaccines to prevent cervical cancer and genital warts: an update.
Dochez C; Bogers JJ; Verhelst R; Rees H
Vaccine; 2014 Mar; 32(14):1595-601. PubMed ID: 24606637
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy.
Santin AD; Bellone S; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
Curr Pharm Des; 2005; 11(27):3485-500. PubMed ID: 16248803
[TBL] [Abstract][Full Text] [Related]
51. Chapter 17: Second generation HPV vaccines to prevent cervical cancer.
Schiller JT; Nardelli-Haefliger D
Vaccine; 2006 Aug; 24 Suppl 3():S3/147-53. PubMed ID: 16950002
[TBL] [Abstract][Full Text] [Related]
52. [Research progress of HPV therapeutic vaccine].
Zhao S; Zhao FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 May; 52(5):556-560. PubMed ID: 29747350
[TBL] [Abstract][Full Text] [Related]
53. Current status and future prospects for human papillomavirus vaccines.
Kim HJ; Kim HJ
Arch Pharm Res; 2017 Sep; 40(9):1050-1063. PubMed ID: 28875439
[TBL] [Abstract][Full Text] [Related]
54. Control of HPV infection and related cancer through vaccination.
Tran NP; Hung CF; Roden R; Wu TC
Recent Results Cancer Res; 2014; 193():149-71. PubMed ID: 24008298
[TBL] [Abstract][Full Text] [Related]
55. Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists.
; Collins Y; Einstein MH; Gostout BS; Herzog TJ; Massad LS; Rader JS; Wright J
Gynecol Oncol; 2006 Sep; 102(3):552-62. PubMed ID: 16979432
[TBL] [Abstract][Full Text] [Related]
56. Molecular Approaches Target to Immunotherapy for HPV-Associated Cancers.
Zhang L; Zhou F; Zhao KN
Curr Cancer Drug Targets; 2017; 17(6):512-521. PubMed ID: 27993116
[TBL] [Abstract][Full Text] [Related]
57. Preventative and therapeutic vaccines for cervical cancer.
Roden R; Wu TC
Expert Rev Vaccines; 2003 Aug; 2(4):495-516. PubMed ID: 14711335
[TBL] [Abstract][Full Text] [Related]
58. Development of prophylactic HPV vaccines.
Gissmann L; Müller M
Coll Antropol; 2007 Apr; 31 Suppl 2():113-5. PubMed ID: 17598512
[TBL] [Abstract][Full Text] [Related]
59. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
[TBL] [Abstract][Full Text] [Related]
60. Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo.
Yang Y; Che Y; Zhao Y; Wang X
Int Immunopharmacol; 2019 Apr; 69():279-288. PubMed ID: 30743204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]